95 related articles for article (PubMed ID: 18195113)
1. Drug-eluting stents: do the risks really outweigh the benefits?
Austin D; Pell JP; Oldroyd KG
Heart; 2008 Feb; 94(2):127-8. PubMed ID: 18195113
[No Abstract] [Full Text] [Related]
2. Drug-eluting stents: a critique.
Melikian N; Wijns W
Heart; 2008 Feb; 94(2):145-52. PubMed ID: 18195121
[TBL] [Abstract][Full Text] [Related]
3. A look at drug eluting stents with optical coherence tomography.
de Smet BJ; Zijlstra F
Eur Heart J; 2007 Apr; 28(8):918-9. PubMed ID: 17347174
[No Abstract] [Full Text] [Related]
4. Drug-eluting stents: a reappraisal.
Garg S; Serruys PW
Heart; 2010 Apr; 96(7):489-93. PubMed ID: 20350985
[No Abstract] [Full Text] [Related]
5. [Benefits and risks of drug-eluting stents].
Zijlstra F
Ned Tijdschr Geneeskd; 2007 May; 151(18):1005-7. PubMed ID: 17508683
[TBL] [Abstract][Full Text] [Related]
6. Neoatherosclerosis as reason for stent failures beyond 5 years after drug-eluting stent implantation.
Taniwaki M; Windecker S; Räber L
Eur Heart J; 2014 Aug; 35(29):1980. PubMed ID: 24497344
[No Abstract] [Full Text] [Related]
7. Drug-eluting stent in saphenous vein graft lesions.
Kornowski R
Catheter Cardiovasc Interv; 2008 Jun; 71(7):894-5. PubMed ID: 18498140
[No Abstract] [Full Text] [Related]
8. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
[TBL] [Abstract][Full Text] [Related]
9. The problem of stent thrombosis associated with drug-eluting stents and the optimal duration of dual antiplatelet therapy.
Ayyanathan S; Hersh D; Coplan NL; Garratt K
Prev Cardiol; 2009; 12(2):59-64. PubMed ID: 19476578
[TBL] [Abstract][Full Text] [Related]
10. Off-label use of drug-eluting stents putting it in perspective.
Grines CL
J Am Coll Cardiol; 2008 Feb; 51(6):615-7. PubMed ID: 18261679
[No Abstract] [Full Text] [Related]
11. The balance of risks and benefits of drug-eluting versus bare-metal stents.
Pfisterer M; Brunner-La Rocca HP; Kaiser C
J Am Coll Cardiol; 2008 Mar; 51(9):972; author reply 972-3. PubMed ID: 18308171
[No Abstract] [Full Text] [Related]
12. Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease.
Ramana RK; Ronan A; Cohoon K; Homan D; Sutherland J; Steen L; Liu J; Loeb H; Lewis BE
Catheter Cardiovasc Interv; 2008 Jun; 71(7):886-93. PubMed ID: 18412238
[TBL] [Abstract][Full Text] [Related]
13. Coexistent in-stent restenosis, late incomplete stent apposition and mural thrombus in a zotarolimus-eluting stent.
Zhang F; Qian J; Ge J
J Invasive Cardiol; 2008 Aug; 20(8):423-5. PubMed ID: 18688068
[TBL] [Abstract][Full Text] [Related]
14. Obesity and cardiovascular thrombotic events in patients undergoing percutaneous coronary intervention with drug-eluting stents.
Wang ZJ; Zhou YJ; Liu YY; Yu M; Shi DM; Zhao YX; Guo YH; Cheng WJ; Nie B; Ge HL; Jia DA; Yang SW; Yan ZX
Heart; 2009 Oct; 95(19):1587-92. PubMed ID: 19592387
[TBL] [Abstract][Full Text] [Related]
15. Value and limitations of target-vessel ischemia in predicting late clinical events after drug-eluting stent implantation.
Zellweger MJ; Kaiser C; Brunner-La Rocca HP; Buser PT; Osswald S; Weiss P; Mueller-Brand J; Pfisterer ME;
J Nucl Med; 2008 Apr; 49(4):550-6. PubMed ID: 18344439
[TBL] [Abstract][Full Text] [Related]
16. [Position paper on the use of drug eluting stents in coronary heart disease].
Mudra H; Bode C; Grube E; de Haan F; Levenson B; Schuler G; Silber S; ;
Z Kardiol; 2004 May; 93(5):416-22. PubMed ID: 15160279
[No Abstract] [Full Text] [Related]
17. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
18. Major adverse cardiac events at follow-up after bare-metal stenting versus drug-eluting stenting in ST-elevated myocardial infarction.
Pierre-Louis B; Aronow WS; Palaniswamy C; Singh T; Ahn C; Asija A; Weiss MB; Kalapatapu K; Pucillo AL; Monsen CE
Am J Cardiol; 2009 Jun; 103(12):1672-4. PubMed ID: 19539074
[TBL] [Abstract][Full Text] [Related]
19. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution.
Li Y; Zheng Z; Xu B; Zhang S; Li W; Gao R; Hu S
Circulation; 2009 Apr; 119(15):2040-50. PubMed ID: 19349321
[TBL] [Abstract][Full Text] [Related]
20. Drug-eluting stents are safe.
Garg S; Serruys P
Clin Pharmacol Ther; 2009 Aug; 86(2):130-2. PubMed ID: 19621006
[No Abstract] [Full Text] [Related]
[Next] [New Search]
